Evidence map›Paper›PMID 34290096›Full record

ArticleScience advances2021

Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging.

Csaba Adori, Teresa Daraio, Raoul Kuiper, Swapnali Barde, Lubica Horvathova, Takashi Yoshitake, Robert Ihnatko, Ismael Valladolid-Acebes, Pauline Vercruysse, Ashley M Wellendorf and 12 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Peripheral Neuropathy in Metabolic Stress.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. [Research advances on hepatocyte zonal changes in metabolic associated fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Csaba AdoriDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden. adorics@gmail.com.ORCID http://orcid.org/0000-0002-6084-5588
Teresa DaraioThe Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.
Raoul KuiperDepartment of Laboratory Medicine, Karolinska Institutet, 17177 Stockholm, Sweden.
Swapnali BardeDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1452-4465
Lubica HorvathovaBiomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.ORCID http://orcid.org/0000-0002-5280-7805
Takashi YoshitakeDepartment of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0002-2445-0132
Robert IhnatkoDepartment of Clinical Chemistry and Department of Clinical and Experimental Medicine, Linköping University, 58285 Linköping, Sweden.ORCID http://orcid.org/0000-0001-5751-3622
Ismael Valladolid-AcebesThe Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7699-9207
Pauline VercruysseThe Rolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.
Ashley M WellendorfDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Roberto GramignoliDepartment of Laboratory Medicine, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0003-3362-4170
Bela BozokyDepartment of Clinical Pathology/Cytology, Karolinska University Hospital, Huddinge, Sweden.
Jan KehrDepartment of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden.
Elvar TheodorssonDepartment of Clinical Chemistry and Department of Clinical and Experimental Medicine, Linköping University, 58285 Linköping, Sweden.ORCID http://orcid.org/0000-0003-0756-7723
Jose A CancelasDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Boris MravecBiomedical Research Center, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.ORCID http://orcid.org/0000-0002-3177-6819
Carl JornsPO Transplantation, Karolinska University Hospital Huddinge, 141 52 Stockholm, Sweden.ORCID http://orcid.org/0000-0001-7727-8113
Ewa EllisDepartment of Transplantation Surgery and Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska University Hospital, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0002-3057-5337
Jan MulderDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0003-3717-5018
Mathias UhlénDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0002-4858-8056
Christina BarkDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID http://orcid.org/0000-0002-0724-6017
Tomas HökfeltDepartment of Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SECincinnati Children's Hospital Medical Center · USInstitute of Experimental Endocrinology of the Slovak Academy of Sciences · SKLinköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic nerves have a complex role in synchronizing liver metabolism. Here, we used three-dimensional (3D) immunoimaging to explore the integrity of the hepatic nervous system in experimental and human nonalcoholic fatty liver disease (NAFLD). We demonstrate parallel signs of mild degeneration and axonal sprouting of sympathetic innervations in early stages of experimental NAFLD and a collapse of sympathetic arborization in steatohepatitis. Human fatty livers display a similar pattern of sympathetic nerve degeneration, correlating with the severity of NAFLD pathology. We show that chronic sympathetic hyperexcitation is a key factor in the axonal degeneration, here genetically phenocopied in mice deficient of the Rac-1 activator Vav3. In experimental steatohepatitis, 3D imaging reveals a severe portal vein contraction, spatially correlated with the extension of the remaining nerves around the portal vein, enlightening a potential intrahepatic neuronal mechanism of portal hypertension. These fundamental alterations in liver innervation and vasculature uncover previously unidentified neuronal components in NAFLD pathomechanisms.

Identifiers

PMID34290096
PMCPMC8294768
OpenAlexW3183325670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.